BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 28459521)

  • 1. Breast cancer stem-like cells can promote metastasis by activating platelets and down-regulating antitumor activity of natural killer cells.
    Wang S; Zhang Y; Cong W; Liu J; Zhang Y; Fan H; Xu Y; Lin H
    J Tradit Chin Med; 2016 Aug; 36(4):530-7. PubMed ID: 28459521
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Platelets impair natural killer cell reactivity and function in endometriosis through multiple mechanisms.
    Du Y; Liu X; Guo SW
    Hum Reprod; 2017 Apr; 32(4):794-810. PubMed ID: 28184445
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Platelet-derived transforming growth factor-beta down-regulates NKG2D thereby inhibiting natural killer cell antitumor reactivity.
    Kopp HG; Placke T; Salih HR
    Cancer Res; 2009 Oct; 69(19):7775-83. PubMed ID: 19738039
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Platelet-derived TGF-β1 mediates the down-modulation of NKG2D expression and may be responsible for impaired natural killer (NK) cytotoxicity in women with endometriosis.
    Guo SW; Du Y; Liu X
    Hum Reprod; 2016 Jul; 31(7):1462-74. PubMed ID: 27130956
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ticagrelor inhibits platelet-tumor cell interactions and metastasis in human and murine breast cancer.
    Gareau AJ; Brien C; Gebremeskel S; Liwski RS; Johnston B; Bezuhly M
    Clin Exp Metastasis; 2018 Feb; 35(1-2):25-35. PubMed ID: 29322294
    [TBL] [Abstract][Full Text] [Related]  

  • 6. NK Cells Lose Their Cytotoxicity Function against Cancer Stem Cell-Rich Radiotherapy-Resistant Breast Cancer Cell Populations.
    Jin H; Kim HJ
    Int J Mol Sci; 2021 Sep; 22(17):. PubMed ID: 34502547
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human cancer cells with stem cell-like phenotype exhibit enhanced sensitivity to the cytotoxicity of IL-2 and IL-15 activated natural killer cells.
    Yin T; Wang G; He S; Liu Q; Sun J; Wang Y
    Cell Immunol; 2016 Feb; 300():41-5. PubMed ID: 26677760
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Effect of aspirin on breast cancer stem cells and stemness of breast cancer].
    Tu L; Zeng Z; Wang L; Luo F
    Zhonghua Yi Xue Za Zhi; 2018 Nov; 98(44):3598-3602. PubMed ID: 30486577
    [No Abstract]   [Full Text] [Related]  

  • 9. Transforming growth factor-beta1 promotes the migration and invasion of sphere-forming stem-like cell subpopulations in esophageal cancer.
    Yue D; Zhang Z; Li J; Chen X; Ping Y; Liu S; Shi X; Li L; Wang L; Huang L; Zhang B; Sun Y; Zhang Y
    Exp Cell Res; 2015 Aug; 336(1):141-9. PubMed ID: 26096658
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunoselection of breast and ovarian cancer cells with trastuzumab and natural killer cells: selective escape of CD44high/CD24low/HER2low breast cancer stem cells.
    Reim F; Dombrowski Y; Ritter C; Buttmann M; Häusler S; Ossadnik M; Krockenberger M; Beier D; Beier CP; Dietl J; Becker JC; Hönig A; Wischhusen J
    Cancer Res; 2009 Oct; 69(20):8058-66. PubMed ID: 19826050
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The killing effect of Tanshinol on breast cancer cells: insight into the reversion of TGF-β1-mediated suppression of NK cell functions.
    Yang C; Qian C; Zhang T; Zheng W; Zhang S; Wang S; Wang A; Zhao Y; Lu Y
    Front Biosci (Landmark Ed); 2021 Nov; 26(11):1106-1118. PubMed ID: 34856757
    [No Abstract]   [Full Text] [Related]  

  • 12. Natural killer cell-based adoptive immunotherapy eradicates and drives differentiation of chemoresistant bladder cancer stem-like cells.
    Ferreira-Teixeira M; Paiva-Oliveira D; Parada B; Alves V; Sousa V; Chijioke O; Münz C; Reis F; Rodrigues-Santos P; Gomes C
    BMC Med; 2016 Oct; 14(1):163. PubMed ID: 27769244
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Spheres derived from the human SK-RC-42 renal cell carcinoma cell line are enriched in cancer stem cells.
    Zhong Y; Guan K; Guo S; Zhou C; Wang D; Ma W; Zhang Y; Li C; Zhang S
    Cancer Lett; 2010 Dec; 299(2):150-60. PubMed ID: 20846785
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bone marrow produces sufficient alloreactive natural killer (NK) cells in vivo to cure mice from subcutaneously and intravascularly injected 4T1 breast cancer.
    van Gelder M; Vanclée A; van Elssen CH; Hupperets P; Wieten L; Bos GM
    Breast Cancer Res Treat; 2017 Feb; 161(3):421-433. PubMed ID: 27915436
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epigenetic Silencing of TAP1 in Aldefluor
    Sultan M; Vidovic D; Paine AS; Huynh TT; Coyle KM; Thomas ML; Cruickshank BM; Dean CA; Clements DR; Kim Y; Lee K; Gujar SA; Weaver ICG; Marcato P
    Stem Cells; 2018 May; 36(5):641-654. PubMed ID: 29341428
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Naringenin prevents TGF-β1 secretion from breast cancer and suppresses pulmonary metastasis by inhibiting PKC activation.
    Zhang F; Dong W; Zeng W; Zhang L; Zhang C; Qiu Y; Wang L; Yin X; Zhang C; Liang W
    Breast Cancer Res; 2016 Apr; 18(1):38. PubMed ID: 27036297
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interleukin-33/ST2 axis promotes breast cancer growth and metastases by facilitating intratumoral accumulation of immunosuppressive and innate lymphoid cells.
    Jovanovic IP; Pejnovic NN; Radosavljevic GD; Pantic JM; Milovanovic MZ; Arsenijevic NN; Lukic ML
    Int J Cancer; 2014 Apr; 134(7):1669-82. PubMed ID: 24105680
    [TBL] [Abstract][Full Text] [Related]  

  • 18. GITR ligand provided by thrombopoietic cells inhibits NK cell antitumor activity.
    Placke T; Salih HR; Kopp HG
    J Immunol; 2012 Jul; 189(1):154-60. PubMed ID: 22649191
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interferon-gamma inhibits aldehyde dehydrogenasebright cancer stem cells in the 4T1 mouse model of breast cancer.
    Zhuang X; Shi G; Hu X; Wang H; Sun W; Wu Y
    Chin Med J (Engl); 2021 Dec; 135(2):194-204. PubMed ID: 34890380
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunophenotypic characterization of sphere-forming cells derived from the human renal cell carcinoma cell line 786-O.
    Shen C; Hu G; Zhang S; Ao X; Zhou Q; Xiao P; Zhong Y
    Am J Transl Res; 2018; 10(12):3978-3990. PubMed ID: 30662644
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.